Some projects

Click a project name below for additional information.

  • Fourth Accelerating COVID-19 Therapeutic Interventions and Vaccines Host Tissue (ACTIV-4HT) 

    Human Tumor Atlas Network: Colon Molecular Atlas Project (ColonMap) 

    Vanderbilt-Ingram Cancer Center (VICC) Contemporary Uro-oncologic Specimen Protocol Biorepository (CUSP)

    Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE)

    Inherited Cancer Registry (ICARE)

    North American Airway Collaborative (NoAAC) Prospective Pragmatic (PR-02) study: Treatment selection in idiopathic subglottic stenosis (iSGS) 

    Influenza and Other Viruses in the AcutelY Ill Network (IVY1 - IVY 6)

    Lung Cancer Mutation Consortium (LCMC):

    • Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs (LCMC1)
    • The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations (LCMC2)
    • Evaluation of Actionable Drivers in Early Stage Lung Cancer, LCRF LEADER study (LCMC4)

    Vanderbilt-Ingram Cancer Center (VICC) / MASLAB Thoracic Biorepository 

    Meharry-Vanderbilt-Tennessee State Cancer Partnership - Tissue Pathology Shared Resource Biorepository (MVTCP TPSP Biorepository)

    Pneumoccal Pneumonia Epidemiology, Urine Serotyping, and Mental Outcomes: The PNEUMO Study

    Risk prediction model for the diagnosis of blood stream infection in febrile pediatric oncology patients without severe neutropenia 

    Respiratory Virus Transmission Network (RVTN)

    Early Identification of Sepsis Signs in Emergency Department (SepSign)

    Tool for Inherited cancer Predisposition counseling and testing Study (TIPS; see under "Point-of-Care Genetic Services") 

    Vanderbilt Hereditary Cancer Registry

    Viruses & Infections in Essential Workers (VIEW)